GH Research News

GH Research Analyst Ratings

Benzinga01:30

Analysts Offer Insights on Healthcare Companies: Veru (VERU) and GH Research (GHRS)

TipRanksMay 3 23:50

GH Research Analyst Ratings

BenzingaMar 5 02:06

HC Wainwright & Co. Reiterates Buy on GH Research, Maintains $40 Price Target

BenzingaMar 5 02:08

Buy Rating for GH Research: Promising Clinical Trials and Strategic Intellectual Property Advances

TipRanksMar 5 00:36

JMP Securities Maintains Market Outperform on GH Research, Lowers Price Target to $39

BenzingaMar 2 00:52

GH Research Analyst Ratings

BenzingaMar 2 00:49

Buy Rating Justified by GH Research's Promising Clinical Trials and Strong Financial Health

TipRanksMar 1 14:36

Optimistic Outlook for GH Research With Progressing Phase 2 Trials and Strong IP Portfolio Reinforcing Buy Rating

TipRanksJan 23 01:57

HC Wainwright & Co. Reiterates Buy on GH Research, Maintains $40 Price Target

BenzingaJan 18 19:14

GH Research Analyst Ratings

BenzingaJan 18 19:13

GH Research Analyst Ratings

BenzingaDec 18, 2023 22:28

HC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $40

BenzingaNov 15, 2023 00:13

GH Research Analyst Ratings

BenzingaNov 15, 2023 00:11

Analysts Offer Insights on Technology Companies: Inuvo (INUV) and GH Research (GHRS)

TipRanksNov 11, 2023 03:50

GH Research Earns 'Buy' Rating: Promising Progress, Proactive Approach, and Solid Financial Standing

TipRanksNov 10, 2023 13:35

Positive Outlook for GH Research Despite FDA's Clinical Hold: An Analysis of GH001's Trials and Prospects

TipRanksOct 4, 2023 02:15

GH Research: Temporary FDA Setback and Promising European Trials Bolster Buy Rating

TipRanksOct 2, 2023 12:15

H.C. Wainwright Sticks to Their Buy Rating for GH Research (GHRS)

TipRanksAug 25, 2023 00:15

GH Research (GHRS) Gets a Buy From JMP Securities

TipRanksAug 23, 2023 22:45